Niagen Bioscience, Inc.
Develops and commercializes a patented NAD+ precursor for supplements, food, beverage & skincare.
NAGE | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 10900 WILSHIRE BLVD, 90024 LOS ANGELES
- Sector:
- Manufacturing
- Industry:
- Manufacture of other food products
Description
Niagen Bioscience, Inc. (formerly ChromaDex) is a global bioscience company dedicated to improving healthspan by advancing the science of cellular health, focusing on Nicotinamide Adenine Dinucleotide (NAD+). With over 25 years of research, the company discovers, develops, and commercializes patented ingredient technologies. Its flagship ingredient, Niagen®, is a proprietary and clinically-studied form of nicotinamide riboside (NR), a precursor to NAD+. Supported by numerous patents and human clinical studies, Niagen® is commercialized through the company's direct-to-consumer brand, Tru Niagen®, and supplied as a key ingredient to partners in the dietary supplement, food, beverage, and skincare markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Niagen Bioscience, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Niagen Bioscience, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Niagen Bioscience, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
